Injective (INJ) trades at $7.95 on October 12, 2026, up 3.71% on the session and positioned above every tracked moving average — but the MACD histogram has converged to zero precisely as price test...

Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.

INJ is sitting above its SMA 7 ($7.52), SMA 20 ($7.62), SMA 50 ($6.56) and SMA 200 ($5.02), as well as its EMA 12 ($7.55) and EMA 26 ($7.28), according to Binance spot data. That full-stack alignment — with price above a rising long-term moving average — describes a constructive medium-term structure. The 24-hour session range of $7.55 to $8.20 confirms buyers absorbed the intraday low and pushed higher, but $8.20 stopped just short of the $8.25 immediate resistance, a small but telling detail.

The Bollinger Band picture reinforces the location: at a %B of 0.7326, INJ sits roughly 73% of the way up the $6.93–$8.32 channel. The upper band at $8.32 clusters tightly with the $8.25 resistance, forming a narrow ceiling between here and the $8.55 strong resistance above it. The daily ATR of $0.61 means a full-range session could reach that upper band or pull back to the SMA 20 at $7.62 within a single candle — there is nothing wide about this range.

0000. That is a convergence point, not a bearish crossover — but the upside impulse that drove the histogram into positive territory has temporarily exhausted itself. Resolution in either direction depends on the next few sessions.

Source link